Halozyme Therapeutics | HALO - Należności Handlowe





Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
Amgen USD 10.23B 1.09B 2026-06
Baxter International USD 1.86B 158M 2026-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cytokinetics USD 6.83M 10.94M 2026-03
DBV Technologies USD 15.1M 1.05M 2026-03
Eli Lilly USD 23.48B 2.3B 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
MannKind USD 43.21M 15.07M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Pfizer USD 16.19B 19M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
United Therapeutics USD 310.3M 1.7M 2026-06
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12